Edwards Lifesciences beat analysts' estimate for fourth-quarter profit on Tuesday, helped by strong demand for its artificial heart valves and other medical devices.

Edwards Lifesciences stock surged late Tuesday — and could retake its 50-day and 200-day lines — after beating fourth-quarter ...

Edwards Lifesciences had a higher profit and sales in its fourth quarter as demand for its products held strong. The medical-technology company posted a profit of $385.6 million, or 65 cents a share, ...

MINNEAPOLIS -- With the Minnesota Timberwolves missing two key contributors and searching for a mid-winter spark, Anthony Edwards played up to his NBA superstar status. Two games. Two days.

Joe Edwards is a Live News Reporter based in Newsweek's London Bureau. He covers U.S. and global news and has a particular interest in U.S. and U.K. politics and social policies. Joe joined ...

After hours: February 7 at 7:29:59 PM EST Loading Chart for EW ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

Funding PP received funding from Edwards Lifesciences and Medtronic for echocardiography core laboratory analyses in the field of transcatheter aortic valve replacement with no direct personal ...